Potential of memory T cells in bridging preoperative chemoradiation and immunotherapy in rectal cancer.

de Mey, Sven;Jiang, Heng;Wang, Hui;Engels, Benedikt;De Ridder, Mark;et.al.
(2018) Radiotherapy & Oncology — (2018)

Files

PotentialofmemoryTcellsinbridgingpreoperativechemoradiationandimmunotherapyinrectalcancer.pdf
  • Open Access
  • Adobe PDF
  • 1.11 MB

Details

Authors
  • de Mey, Sven
    Author
  • Jiang, Heng
    Author
  • Wang, Hui
    Author
  • Engels, Benedikt
    Author
  • Author
  • De Ridder, Mark
    Author
Show more
Abstract
The management of locally advanced rectal cancer has passed a long way of developments, where total mesorectal excision and preoperative radiotherapy are crucial to secure clinical outcome. These and other aspects of multidisciplinary strategies are in-depth summarized in the literature, while our mini-review pursues a different goal. From an ethical and medical standpoint, we witness a delayed implementation of novel therapies given the cost/time consuming process of organizing randomized trials that would bridge an already excellent local control in cT3-4 node-positive disease with long-term survival. This unfortunate separation of clinical research and medical care provides a strong motivation to repurpose known pharmaceuticals that suit for treatment intensification with a focus on distant control. In the framework of on-going phase II-III IG/IMRT-SIB trials, we came across an intriguing translational observation that the ratio of circulating (protumor) myeloid-derived suppressor cells to (antitumor) central memory CD8+ T cells is drastically increased, a possible mechanism of tumor immuno-escape and spread. This finding prompts that restoring the CD45RO memory T-cell pool could be a part of integrated adjuvant interventions. Therefore, the immunocorrective potentials of modified IL-2 and the anti-diabetic drug metformin are thoroughly discussed in the context of tumor immunobiology, mTOR pathways and revised Warburg effect.
Affiliations

Citations

de Mey, S., Jiang, H., Wang, H., Engels, B., Gevaert, T., Dufait, I., Feron, O., Aerts, J., Verovski, V., & De Ridder, M. (2018). Potential of memory T cells in bridging preoperative chemoradiation and immunotherapy in rectal cancer. Radiotherapy & Oncology. Accepted/in-press. https://doi.org/10.1016/j.radonc.2018.04.003 (Original work published 2018)